Fitch also affirmed the “AA-” rating on Munson’s $76 million of series 2011A revenue refunding bonds and $25 million of series 2011B variable rate revenue refunding bonds.
The rating assignment was based on a number of factors, including the system’s robust operating profitability. Munson has recorded an average operating EBITDA of 10.8 percent since 2010 and 11 percent in fiscal year 2014.
The rating assignment was also supported by the system’s light pro forma debt burden, strong liquidity and 88 percent leading market share position in its primary service area.
Going forward, Fitch predicts Munson will need to sustain its financial profile and leading market share position while also successfully completing its new cancer center and integrating two hospitals.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
